CPhI India 2026
Dates: 23rd – 26th November 2026
Location: IICC Yashobhoomi, Dwarka, Delhi, India
There are pharmaceutical events in India. There are significant pharmaceutical events in India. And then there is CPhI India — three days at the India International Convention Centre in Dwarka where the Indian pharmaceutical industry and the global supply chain that depends on it come together in the most important pharmaceutical gathering on the Indian subcontinent.
India is the world's pharmacy. This is not a marketing phrase. It is an accurate description of a country that produces approximately twenty percent of the world's generic medicines, that supplies forty percent of the generic drugs consumed in the United States and that has built a pharmaceutical manufacturing capability that the global healthcare system depends on in ways that recent years have made very clear.
CPhI India 2026 runs from the 23rd to the 25th of November at IICC Yashobhoomi — the India International Convention Centre in Dwarka, Delhi. A venue of genuine scale in a city of genuine significance. Three days. The full Indian pharmaceutical value chain — APIs, formulations, excipients, contract manufacturing, drug delivery, packaging and the technology and laboratory services that the Indian pharmaceutical industry produces at the volume and increasingly at the quality that the global market requires.
The Exhibition. The Indian Pharmaceutical Industry at Scale.
The CPhI India floor brings together the Indian pharmaceutical supply chain in the concentrated form that the global industry travels to Delhi in November for. The API manufacturers from the pharmaceutical hubs of Hyderabad and Ahmedabad and Mumbai — the companies that produce the active ingredients that generic medicines across the world are made from. The formulation manufacturers. The excipient suppliers. The contract development and manufacturing organisations that have been building their global quality credentials.
The Indian pharmaceutical companies presenting their manufacturing capabilities to global buyers who understand that Indian production is not an alternative to quality but increasingly the definition of it in the generic sector. The quality systems that the FDA and EMA have been approving. The manufacturing facilities that have been built to the standards that the global regulatory environment requires.
International pharmaceutical companies attending with the sourcing requirements of organisations that have understood India's position in the generic supply chain for decades and are here to manage their relationships with it. New global companies discovering the depth of Indian pharmaceutical manufacturing capability that a briefing document cannot convey and the IICC floor can.
If you need help with your next event, incentive, meeting, conference or group to India, please
The Meetings. The Indian Pharmaceutical Relationships.
CPhI India is built around meetings. The global buyer and the Indian manufacturer. The innovator and the contract development organisation. The pharmaceutical company with the formulation requirement and the Indian manufacturer with the capacity, the quality systems and the regulatory approvals to meet it.
Indian pharmaceutical companies are export-focused in the way that the global market has made them — the FDA approvals, the EMA certifications, the WHO prequalifications that the Indian industry has been accumulating as evidence that its manufacturing capability meets the standards of the markets it serves. CPhI India is where those credentials are presented to the buyers who need to evaluate them in the format that three days of concentrated access provides.
The meetings prepared for. The documentation reviewed in advance. The conversations that the rest of the year conducts by email and video call advancing significantly in three days at Yashobhoomi in November.
The Content. The Indian Pharmaceutical Context.
The CPhI India conference programme covers the Indian pharmaceutical industry and its global regulatory context. The CDSCO regulatory developments. The FDA and EMA expectations that the Indian industry is working to meet. The quality systems and the manufacturing standards that the global pharmaceutical supply chain requires of its Indian suppliers.
Speakers from inside the Indian pharmaceutical industry. Regulatory representatives from the CDSCO and international agencies. The content that gives the exhibition visits the regulatory and market context that productive supply chain relationships require.
The Indian pharmaceutical policy environment. The production linked incentive schemes. The investment in pharmaceutical infrastructure that the Indian government has been making and that the industry has been building on. The content that gives the global participants the understanding of where the Indian pharmaceutical industry is in November 2026 and where it is heading.
Delhi in November. Which Is Delhi at Its Best.
November is Delhi's finest month. The monsoon has gone. The brutal summer heat is a distant memory. The air in November has the cool, clear quality of a north Indian winter arriving with the particular crispness that the season produces before the fog of December settles.
The India International Convention Centre at Yashobhoomi in Dwarka is a new-generation venue — one of the most significant convention facilities in India, built to the standards that international events of this scale require and providing the infrastructure that CPhI India's ambitions deserve.
Delhi beyond the venue is Delhi — one of the world's great cities in all its layered, chaotic, magnificent complexity. Old Delhi for the history that the sixteenth century left in the Red Fort and the Jama Masjid and the lanes of Chandni Chowk. New Delhi for the colonial grandeur of Lutyens' boulevards and India Gate and the government buildings that independent India inherited from the British and has been using purposefully ever since.
The food — North Indian cuisine in the city that defines it. The butter chicken that Delhi's restaurants produce in the original rather than the approximation. The street food of Chandni Chowk. The Old Delhi breakfast of parathas and chai that November mornings in the capital make feel exactly right.
The Qutub Minar for the afternoon that wants history older than the Mughals. Humayun's Tomb for the garden and the architecture that predates the Taj Mahal and is worth the visit independently of that context. The Lodhi Garden for the morning before the first session when Delhi's medieval tombs and manicured lawns provide the perspective that the pharmaceutical supply chain benefits from.
For DMCs and Incentive Planners: Delhi in November With a Purpose
For travel professionals, CPhI India 2026 is the Indian pharmaceutical supply chain event that combines three days of the most concentrated Indian pharmaceutical industry access with Delhi in November — the city in its finest month, the food at its most available, the history at its most accessible.
The pre-event arrival that uses Delhi properly. Old Delhi for the Mughal history and the Chandni Chowk food. New Delhi for the Lutyens boulevards and India Gate. Humayun's Tomb and the Qutub Minar for the UNESCO heritage that Delhi provides in density that few cities match.
For incentive groups within the pharmaceutical supply chain sector, CPhI India 2026 provides the professional substance of the most significant Indian pharmaceutical event alongside Delhi in November. The history. The food. The city at its most navigable and most itself. The particular quality of North India in late November that clients describe with the enthusiasm of people who arrived for the pharmaceutical supply chain and discovered that India had considerably more to offer around it.
For more information about the event visit this page.
If you would like to see more events like these visit our events page!
Disclaimer:
We have researched the dates of this event for you. However, before you plan and book, please always check with the event organiser directly to see if there have been any changes and if the event still takes place.
